Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

Stacy R. Lindborg, Namita A. Goyal, Jonathan Katz, Matthew Burford, Jenny Li, Haggai Kaspi, Natalie Abramov, Bruno Boulanger, James D. Berry, Katharine Nicholson, Tahseen Mozaffar, Robert Miller, Liberty Jenkins, Robert H. Baloh, Richard Lewis, Nathan P. Staff, Margaret Ayo Owegi, Bob Dagher, Netta R. Blondheim-Shraga, Yael GothelfYossef S. Levy, Ralph Kern, Revital Aricha, Anthony J. Windebank, Robert Bowser, Robert H. Brown, Merit E. Cudkowicz

Brainstorm Cell Therapeutics
University of California at Irvine
California Pacific Medical Center
Cedars-Sinai Medical Center
Brainstorm Cell Therapeutics
Pharmalex GmbH
Harvard University
Mayo Clinic Rochester, MN
University of Massachusetts Medical School
St. Joseph's Hospital and Medical Center, Phoenix

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Sort by
Weight
Alphabetically

Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes

Fingerprint

Keyphrases

Neuroscience

Biochemistry, Genetics and Molecular Biology